Here, we combined DNA labeling with Ki67 staining to distinguish cells in G0, G1, and S/G2/M phases and found a small fraction of CLL cells in S/G2/M phase readily detectable in the PB of all patients, regardless of IGHV mutation status or disease course. Here, MKI67 is linked to B-cell chronic lymphocytic leukemia.